N-(tert)-butyloxycarbonyl-β, β-cyclopentyl-cysteine (acetamidomethyl)-methyl ester for synthesis of novel peptidomimetic derivatives

Protein and Peptide Letters

Volumn 17, Issue 7, 2010, Pages 925-929

  Mollica, Adriano ^a   Feliciani, Federica ^a   Stefanucci, Azzurra ^a   Cacciatore, Ivana ^a   Cornacchia, Catia ^a   Torino, Domenica ^b   Pinnen, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

, dialkyl amino acids; space; Cysteine; Peptides; Peptidomimetic; Thiols

Indexed keywords

BIOMIMETIC MATERIAL; BUCILLAMINE; CYCLOPENTANE DERIVATIVE; CYSTEINE; DRUG DERIVATIVE; FURAN DERIVATIVE; PEPTIDE; SODIUM DERIVATIVE; SODIUM HYDRIDE; TETRAHYDROFURAN; THIOL DERIVATIVE;

ARTICLE; CHEMISTRY; SYNTHESIS; THERMODYNAMICS; ANALOGS AND DERIVATIVES;

BIOMIMETIC MATERIALS; CYCLOPENTANES; CYSTEINE; FURANS; PEPTIDES; SODIUM COMPOUNDS; SULFHYDRYL COMPOUNDS; THERMODYNAMICS;

EID: 77954721438     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610791306760     Document Type: Article

References (46)

1. Leung-Toung, R.; Li, W.; Tam, T.F.; Karimian, K. Thiol-dependent enzymes and their inhibitors: A review. Curr. Med. Chem., 2002, 9, 979-1002.
2. Polgar, L. Catalytic mechanisms of cysteine peptidases. In: Hand-book of Proteolytic Enzymes, 2th Ed.; Elsevier, London, UK, 2004, Vol. 2, pp. 1072-1079.
3. Brandes, N.; Schmitt, S.; Jakob, U. Thiol-based redox switches in eukaryotic proteins. Antioxid. Redox Signaling, 2009, 11, 997-1014.
4. Koreaki, I. Redox Control of Protein Processing: From Electrons to Cells. Antioxid. Redox Signaling, 2006, 8, 729-730.
5. Chaudhuri, A. Thiol/disulfide exchange reaction: A key regulatory process in biological systems. Curr. Sci., 1995, 68, 692-8.
6. Kakhnover, N.B.; Khmelevskii L. V. Glutathione-S-transferases as detoxication enzymes. Ukr. Biokhim. Zh., 1983, 55, 86-92.
7. Ketter, B.; Coles, B.; Meyer, D.J. Environ. Health Perspect., 1983, 49, 59-69.
8. Tiunov, L.A.; Ivanova, V.A. Role of Glutathione in detoxification processes. Vestnik Akad. Meditsin. SSSR, 1988, 1, 62-9.
9. Ross, D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol., Ther., 1988, 37, 231-49.
10. Sch midt, U.; Grafen, P.; Goedde, H.W. Chemistry and biochemistry of alpha-lipoic acid. Angew. Chem., (Int. Ed. Engl.), 1965, 4, 846-56.
11. Packer, L.; Witt, E.H.; Tritscheler, H. J. alpha-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med., 1995, 19, 227-50.
12. Lynch, M.A. Lipoic acid confers protection against oxidative injury in non-neuronal and neuronal tissue. Nutr. Neurosci., 2001, 4, 419-38.
13. Sauer, J.; Tabet, N.; Howard, R. Alpha lipoic acid for dementia. Cochrane database of systematic reviews 2004. http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004244/frame.html. (accessed, Feb 12, 2010).
14. Bast, A.; Haenen, G.R.M.M. -Lipoic acid and N-acetylcysteine: New concepts for old drugs. Antioxid. Health Disease, 1995, 2, 409-25.
15. Gassen, M.; Youdim, M.B.H. Free radical scavengers: chemical concepts and clinical relevance. J. Neural. Transm. Suppl., 1999, 56, 193-210.
16. Bartov, O.; Sultana, R.; Butterfield, D. A.; Atlas, D. Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from A (1-42) toxicity. Brain Res., 2006, 1069, 198-206.
17. Martinez Banaclocha, M. N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease. Brain Res., 2000, 859, 173-5.
18. LoPachin, R.M.; Barber, D.S. Synaptic Cysteine Sulfhydryl Groups as Targets of Electrophilic Neurotoxicants. Toxicol. Sci., 2006, 94, 240-255.
19. Suketa, Y. Relation between Alzheimer's disease and metal metabolism. Farumashia, 2007, 43, 881-884.
20. Pinnen, F.; Cacciatore, I.; Cornacchia, C.; Sozio, P.; Cerasa, L. S.; Iannitelli, A.; Nasuti, C.; Cantalamessa, F.; Sekar, D.; Gabbianelli, R.; Falcioni, M. L.; Di Stefano, A.; Design, Synthesis and Biological Evaluation of Glutathione Peptidomimetics as Components of Anti-Parkinson Prodrugs. J. Med. Chem., 2009, 52, 559-563.
21. Hirohata, S.; Lipsky, P.E. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug. Clinic. Immunol. Immunopatol., 1993, 66, 43-51.
22. Horwitz, L.D. Bucillamine: a potent thiol donor with multiple clinical applications. Cardiovasc. Drug Rev., 2003, 21, 77-90.
23. Hirohata, S. Penicillamine and bucillamine. Ensho to Men-eki 1998, 6, 561-567.
24. Jalilehvand, F.; Leung, B.O.; Mah, V. Cadmium(II) Complex Formation with Cysteine and Penicillamine. Inorg. Chem., 2009, 48, 5758-771.
25. Hruby, V.J.; Al-Obeidi, F.; Kazmierski, W. Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations. Biochem. J., 1990, 268, 249-262.
26. Hruby, V.J.; Li, G.; Haskell-Luevano, C.; Shenderovich, M. Design of peptides, proteins, and peptidomimetics in chi space. Biopolymers, 1997, 43, 219-266.
27. Cowell, S.M.; Lee, Y.S.; Cain, J.P.; Hruby, V.J. Exploring ramachandran and Chi space: conformationally constrained amino acids and peptides in the design of bioactive polypeptide ligands. Curr. Med. Chem. 2004, 11, 2785-2798.
28. Hruby, V.J.; Balse, P.M. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Curr. Med. Chem., 2000, 7, 945-970.
29. Shiller, P.W.; Wilkes, B.C. In: NIDA Research Monograph: Opioid Peptides. An update. 1998; 87, pp. 60-73.
30. Gibson, S.E.; Guillo, N.; Tozer, M. J. Towards control of -space: Conformationally constrained analogues of Phe, Tyr, Trp and His. Tetrahedron, 1999, 55, 585-615.
31. Horwell, D.C.; McKiernan, M.J.; Naylor, D.; Osborne, S.A. A Trp in chi space Lett. Pept. Sci., 1998, 5, 143-145.
32. Valachova, K.; Hrabarova, E.; Gemeiner, P.; Soltes, L. Study of pro- and anti-oxidative properties of D-penicillamine in a system comprising high-molar-mass hyaluronan, ascorbate, and cupric ions. Neuroendocrin. Lett., 2008, 29, 697-701.
33. Wacker, A.; Chandra, P.; Heyl, E. On the mechanism of action of D- and L-penicillamine. Arzneim.-Forsch., 1966, 16, 825-7.
34. Raab, W.; Windisch, J. Effect of D-penicillamine on the metabolism of bacteria and yeasts. Mykosen 1972, 15, 237-43.
35. Rao, S.N.; Parthasarathy, R.; Cole, F.E. Structure and conformation of amino acids containing sulfur. I. Crystal and molecular structure of L-β, β'-dimethylcysteine (penicillamine) hydrochloride monohydrate. Acta Crystallogr. Section B Struct. Crystallogr. Crystal. Chem., 1973, 29, 2373-8.
36. Mosberg, H.I.; Hurst, R.; Hruby, V.J.; Galligan, J.J.; Burks, T.F.; Gee, K.; Yamamura, H.I. [D-Pen2, L-Cys5]enkephalinamide and[D-Pen2, D-Cys5] enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity. Biochem. Biophys. Res. Comm, 1982, 106, 506-12.
37. Hruby, V.J.; Toth, G.; Gehrig, C.A.; Kao, L.F.; Knapp, R.; Lui, G.K.; Yamamura, H.I.; Kramer, T.H.; Davis, P.; Burks, T.F. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin. J. Med. Chem., 1991, 34, 1823-30.
38. Stanfield, C.F.; Cody, W.L.; Hruby, V.J. Preparation of β, β-Dialkyl Analogs of Cysteine Suitable for Peptide Synthesis. J. Org. Chem., 1986, 51, 5153-6.
39. Stanfield, C.F.; Hruby, V.J. The Michael Addition of Sulfur Anions to β, β-Substituted Nα-Formy1-α, β-Dehydroamino Acid Esters. Synt. Comm., 1988, 18, 531-43.
40. Bryan, W. M.; Callahan, J. F.; Codd, E. E.; Lemieux, C.; Moore, M. L.; Schiller, P.W.; Walker, R.F.; Huffman, W.F. Cyclic enkephalin analogues containing alpha-amino-beta-mercaptobeta,beta-pentamethylenepropionic acid at positions 2 or 5. J. Med. Chem., 1989, 32, 302-4.
41. Veber, D.F.; Milkowski, J.D.; Varga, S.L.; Denkewalter, R.G.; Hirschmann, R. Acetamidomethyl. A novel thiol protecting group for cysteine. J. Am. Chem. Soc., 1972, 94, 5456-61.
42. Milkowski, J.D.; Veber, D.F.; Hirschmann, R. Thiol protection with the acetamidomethyl group: S-acetamidomethyl-L-cysteine hydrochloride. Org. Synth., 1980, 59, 190-4.
43. Cavalier, F.; Daunis, J.; Jacquier, R. Bibliographic and critical study of thiol protection in peptide synthesis. Bull. Soc. Chim. Fr., 1990, 2, 210-25.
44. Tarbell, D.S.; Yamamoto, Y.; Pope, B.M. New Method to Prepare N-t-Butoxycarbonyl Derivatives and the Corresponding Sulfur Analogs from di-t-Butyl Dicarbonate or di-t-Butyl Dithiol Dicarbonates and Amino Acids. Proc. Natl. Acad. Sci. U.S.A., 1972, 69, 730.
45. Keller, O.; Keller, W.E.; van Look, G.; Weisen, G. Tert-butoxycarbonylation of amino acids and their derivatives: N-tert-butoxycarbonyl-Lphenylalanine. Org. Synth., 1984, 63, 160-170.
46. Mollica, A.; Davis, P.; Ma, S.-W.; Porreca, F.; Lai, J.; Hruby, V.J. Synthesis and biological activity of the first cyclic biphalin analogues. Bioorg. Med. Chem. Lett., 2006, 2, 367-372.